Mark Andrew White serves as Executive at ROCKET PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Mark Andrew White has executed 4 insider transactions totaling $370.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 8, 2024 involved selling 3,026 shares valued at $61.7K.
Mark Andrew White currently holds 72,220 shares of ROCKET PHARMACEUTICALS, INC. (RCKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Andrew White has been a net seller of RCKT stock. They have purchased $0 and sold $370.5K worth of shares.
Mark Andrew White's most recent insider trade was on Jul 8, 2024, when they sold 3,026 shares at $20.40 per share.
Get notified when new Form 4 filings are submitted
| $24.64 |
| Discretionary |
| Feb 16, 2024 | RCKT | $0 | Award | 11,096 | $N/A | Discretionary |
| Apr 4, 2023 | RCKT | $0 | Award | 76,662 | $N/A | Discretionary |